SCNIScinai Immunotherapeutics Ltd.
SCNI holders
Who holds Scinai Immunotherapeutics Ltd., from the managers’ Form 13F reports for the quarter ended Sep 30, 2026.
Moves this quarter
Added
- HRT Financial LP+19.5K$44
Reduced
- Citadel Advisors LLC−41.5K$29.5K
- Rhumbline Advisers−12.2K$1.9K
- Morgan Stanley−53$7
New
- Managers
- 6
- Shares held
- 53.7K
- Value held
- $31.4K
- Opened
- 2
- Closed
- 6
Form 13F covers managers with $100 million or more. Positions are as of the quarter end and filed up to 45 days later; the latest quarter fills in as reports land.
| Manager | Shares | Change | Value | Of portfolio | Filed |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 20.8K | −66.7% | $29.5K | 0% | Nov 16, 2026 |
| Rhumbline Advisers | 1.3K | −90.0% | $1.9K | 0% | Nov 10, 2026 |
| HRT Financial LP | 31.6K | +161.6% | $44 | 0.1% | Nov 13, 2026 |
| Morgan Stanley | 5 | −91.4% | $7 | 0% | Nov 13, 2026 |
| JPMorgan Chase & Co | 2 | New | $3 | 0% | Nov 12, 2026 |
| Danske Bank A/S | 1 | New | $1 | 0% | Nov 9, 2026 |